Pfizer CEO Bourla’s Pay Climbed 17% to $21 Million in 2020

March 12, 2021, 3:32 PM UTC

Pfizer Inc. paid Chief Executive Officer Albert Bourla $21 million in total compensation last year, as the pharmaceutical giant became the first to gain U.S. authorization for a coronavirus vaccine.

The overall pay package, which included salary, bonus, stock and other incentive pay, represented a 17% increase from Bourla’s compensation in 2019, when he was paid a total of $17.9 million, according to a securities filing on Friday.

Bourla has become the highly visible face of a company at the center of global efforts to halt the Covid-19 pandemic. The vaccine that Pfizer developed with German partner BioNTech SE was ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.